Champlain Investment Partners’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4M Sell
355,746
-249,369
-41% -$11.6M 0.55% 88
2026
Q1
$21.9M Sell
605,115
-146,883
-20% -$6.14M 0.28% 108
2025
Q4
$35.4M Buy
751,998
+417,875
+125% +$17.7M 0.36% 99
2025
Q3
$10.9M Buy
334,123
+2,103
+0.6% +$75K 0.08% 134
2025
Q2
$13.7M Buy
+332,020
New +$12.8M 0.1% 133

Other funds holding BRKR

Champlain Investment Partners's BRKR Position: Q2 2026 in Review

Champlain Investment Partners reduced its Bruker (BRKR) stake by 41% in Q2 2026, selling an estimated $11.6M and leaving 355,746 shares worth $21.4M. The position accounts for 0.55% of the portfolio, ranked #88.

Champlain Investment Partners first reported a position in BRKR in Q2 2025 and has held it in 5 quarters since. The position peaked at $35.4M in Q4 2025. 417 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Champlain Investment Partners held 355,746 shares of Bruker worth $21.4M as of Q2 2026.
  • Champlain Investment Partners sold 249,369 Bruker shares in Q2 2026, an estimated $11.6M.
  • Bruker made up 0.55% of Champlain Investment Partners's portfolio in Q2 2026, its #88 holding.
  • Champlain Investment Partners first reported a position in Bruker in Q2 2025 and has held it in 5 quarters since.
  • Champlain Investment Partners's Bruker position peaked at $35.4M in Q4 2025.
  • 417 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Champlain Investment Partners's 13F filing for Q2 2026, filed 12 Aug 2026.